Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Rowe

Showing results (151-160 of 275) with videos related to

Pageof 28
Sort By:
Blood|August 19, 2010
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999Larry D Cripe, Hajime Uno, Elisabeth M Paietta, et al.
Blood|March 27, 2004
Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemiasElisabeth Paietta, Adolfo A Ferrando, Donna Neuberg, et al.
British Journal of Haematology|June 19, 2021
Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemiaPeter H Wiernik, Zhuoxin Sun, Larry D Cripe, et al.
Lancet (London, England)|February 21, 2004
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemiaAdolfo A Ferrando, Donna S Neuberg, Richard K Dodge, et al.
Journal of Crohn'S & Colitis|November 18, 2021
Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRNOhad Atia, Sasha Harel, Natan Ledderman, et al.
British Journal of Haematology|April 30, 2015
Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trialAndre Goy, Sevgi Kalayoglu Besisik, Johannes Drach, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2017
Synergistic antileukemic therapies in <i>NOTCH1</i>-induced T-ALLMarta Sanchez-Martin, Alberto Ambesi-Impiombato, Yue Qin, et al.
American Journal of Hematology|August 1, 2012
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-upTsila Zuckerman, Tamar Katz, Nuhad Haddad, et al.
Blood|March 19, 2011
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicinHugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Bone Marrow Transplantation|December 3, 2024
Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I studyJoseph P McGuirk, Leland Metheny, Luis Pineiro, et al.
Pageof 28

Showing results (151-160 of 275) with videos related to

Sort By:
Pageof 28
Blood|August 19, 2010
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999Larry D Cripe, Hajime Uno, Elisabeth M Paietta, et al.
Blood|March 27, 2004
Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemiasElisabeth Paietta, Adolfo A Ferrando, Donna Neuberg, et al.
British Journal of Haematology|June 19, 2021
Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemiaPeter H Wiernik, Zhuoxin Sun, Larry D Cripe, et al.
Lancet (London, England)|February 21, 2004
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemiaAdolfo A Ferrando, Donna S Neuberg, Richard K Dodge, et al.
Journal of Crohn'S & Colitis|November 18, 2021
Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRNOhad Atia, Sasha Harel, Natan Ledderman, et al.
British Journal of Haematology|April 30, 2015
Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trialAndre Goy, Sevgi Kalayoglu Besisik, Johannes Drach, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2017
Synergistic antileukemic therapies in <i>NOTCH1</i>-induced T-ALLMarta Sanchez-Martin, Alberto Ambesi-Impiombato, Yue Qin, et al.
American Journal of Hematology|August 1, 2012
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-upTsila Zuckerman, Tamar Katz, Nuhad Haddad, et al.
Blood|March 19, 2011
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicinHugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Bone Marrow Transplantation|December 3, 2024
Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I studyJoseph P McGuirk, Leland Metheny, Luis Pineiro, et al.
Pageof 28